Prevalence of polyneuropathy in prediabetes and diabetes is associated with abdominal obesity and macroangiopathy: The Monica/Kora Augsburg surveys S2 and S3

Diabetes Care

Volumn 31, Issue 3, 2008, Pages 464-469

  Ziegler, Dan ^a   Rathmann, Wolfgang ^b   Dickhaus, Thorsten ^b   Meisinger, Christa ^c   Mielck, Andreas ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE; HEALTH SURVEY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POLYNEUROPATHY; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; VASCULAR DISEASE; WAIST CIRCUMFERENCE; ABDOMINAL FAT; GERMANY; GLUCOSE INTOLERANCE; METABOLISM; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; STATISTICAL MODEL;

ABDOMINAL FAT; ADULT; AGED; DIABETES COMPLICATIONS; FEMALE; GERMANY; GLUCOSE INTOLERANCE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; POLYNEUROPATHIES; PREDIABETIC STATE; PREVALENCE; REGRESSION ANALYSIS;

EID: 44449144074     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1796     Document Type: Article

References (47)

1. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD: The incidence and life-time prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123:665-676, 2000
2. Shaw JE, Zimmet PZ, Gries FA, Ziegler D: Epidemiology of Diabetic Neuropathy. In Textbook oj Diabetic Neuropathy. Gries FA, Cameron NE, Low PA, Ziegler D, Eds. Thieme, Stuttgart, New York, 2003, p. 64-82
3. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:150-154, 1993
4. Ziegler D, Gries FA, Mühlen H, Rathmann W, Spüler M, Lessmann F, the DiaCAN Multicenter Study Group: Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diabete Metab 19:143-151, 1993
5. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, Greene DA, Negrin P, Santeusanio F, the Italian Diabetic Neuropathy Committee: A multicenter study on the prevalence of diabetic neuropathy in Italy. Diabetes Care 20:836-843, 1997
6. Cabezas-Cerrato J, Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS): The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia 41:1263-1269, 1998
7. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH; EURODIAB Prospective Complications Study Group: Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341-350, 2005
8. Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ: Prevalence of diabetic complications in relation to risk factors. Diabetes 35:1332-1339, 1986
9. Fujimoto WY, Leonetti DL, Kinyoun JL, Shuman WP, Stolov WC, Wahl PW: Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Diabetes 36: 730-739, 1987
10. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF Sensory neuropathy in non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. Am J Epidemiol 131:633-643
11. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ 3d, Service FJ: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993
12. Harris M, Eastman R, Cowie C: Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 16:1446-1452, 1993
13. Shaw JE, Hodge AM, de Courten M, Dowse GK, Gareeboo H, Tuomilehto J, Alberti KGMM, Zimmet PZ: Diabetic neuropathy in Mauritius: prevalence and risk factors. Diabetes Res Clin Prac 42:131-139, 1998
14. Verhoeven S, van Ballegooie E, Casparie AF: Impact of late complications in type 2 diabetes in a Dutch population. Diabet Med 8:435-438, 1991
15. Walters DP, Gatting W, Mullee MA, Hill RD: The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med 9:349-353, 1992
16. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L; 1999-2000 national health and nutrition examination survey: Prevalence of lower-extremity disease in the U.S. adult population ≥40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care 27:1591-1597, 2004
17. Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ; AusDiab Study Group: Foot complications in type 2 diabetes: an Australian population-based study. Diabet Med 20:105-113, 2003
18. Hanley AJ, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, Spence JD, House AA, Brown E, Schoales B, McLaughlin JR, Klein R, Zinman B: Complications of type 2 diabetes among Aboriginal Canadians: prevalence and associated risk factors. Diabetes Care 28: 2054-2057, 2005
19. Cheng YJ, Gregg EW, Kahn HS, Williams DE, De Rekeneire N, Narayan KM: Peripheral insensate neuropathy - a tall problem for US adults? Am J Epidemiol 164:873-880, 2006
20. Koopman RJ, Mainous AG, Liszka HA, Colwell JA, Slate EH, Carnemolla MA, Everett CJ: Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med 4:427-432, 2006
21. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ, O'Brien PC: Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 22:1479-1486, 1999
22. Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJ, Klein CJ, Rizza RA, Pach JM, Klein R, Larson TS, Melton LJ, O'Brien PC: Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care 29:2282-2288, 2006
23. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF: Risk factors for distal symmetric neuropathy in NIDDM: The San Luis Valley Diabetes Study. Diabetes Care 17:1172-1177, 1994
24. Maser RE, Steenkiste AR, Dorman JS, Kamp Nielsen V, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA, Orchard TJ: Epidemiological correlates of diabetic neuropathy: report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38:1456-1461, 1989
25. Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ: Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 46:665-670, 1997
26. Russell JW, Feldman EL: Impaired glucose tolerance - does it cause neuropathy? Muscle Nerve 24:1109-1112, 2001
27. Singleton JR, Smith AG: Therapy insight: neurological complications of prediabetes. Nat Clin Pract Neurol 2:276-282, 2006
28. Kissel JT: Peripheral neuropathy with impaired glucose tolerance: a sweet smell of success? Arch Neurol 63:1055-1056, 2006
29. Dyck PJ, Dyck PJ, Klein CJ, Weigand SD: Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve 36:536-541, 2007
30. de Neeling JN, Beks PJ, Bertelsmann FW, Heine RJ, Bouter LM: Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study. Diabet Med 13:960-966, 1996
31. Eriksson KF, Nilsson H, Lindgärde F, Osterlin S, Dahlin LB, Lilja B, Rosen I, Sundkvist G: Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med 11:279-285, 1994
32. Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP: Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol 63:1075-1079, 2006
33. Smith AG, Singleton JR: Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci 242:9-14, 2006
34. Hughes RA, Umapathi T, Gray IA, Gregson NA, Noori M, Pannala AS, Proteggente A, Swan AV: A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 127:1723-1730, 2004
35. WHO MONICA Project Principal Investigators, prepared by H. Tunstall-Pedoe: The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 34:105-114, 1988
36. Keil U, Cairns V, Döring A: MONICA-Project, Region Augsburg, manual of operations, survey. In GSF-Bericht 20, Munich, Germany, Forschungszentrum für Gesundheit und Umwelt, 1985
37. Hense HW, Filipiak B, Döring A: Tenyear trends of cardiovascular risk factors in the MONICA Augsburg Region in Southern Germany: results from the 1984/85, 1989/90 and 1994/1995 surveys. Cardiovasc Dis Prev 1:318-327, 1998
38. Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Löwel H: Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med 162:82-89, 2002
39. Rathmann W, Haastert B, Icks A, Löwel H, Meisinger C, Holle R, Giani G: High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening: the KORA survey 2000. Diabetologia 46:182-189, 2003
40. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
41. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289, 1994
42. Bernstein EF, Fronek A: Current status of noninvasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am 62:473-487, 1982
43. World Health Organization: Report of a WHO Consultation: Definition, Diagnosis and Classification oj Diabetes Mellitus and Its Complications. Geneva, World Health Org., 1999 (Tech. Rep. Ser., no. WHO/NCD/NCS/99.2)
44. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group: The metabolic syndrome: a new worldwide definition. Lancet 366:24-30, 2005
45. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752, 2005. [Erratum in: Circulation 112:e297-e298]
46. Sosenko JM, Kato M, Soto R, Goldberg RB: Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening. Diabetes Care 15:847-852, 1992
47. Barr EL, Wong TY, Tapp RJ, Harper CA, Zimmet PZ, Atkins R, Shaw JE; AusDiab Steering Committee: Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab Study. Diabetes Care 29:1114-1116, 2006